Home > Chemotherapeutics > TXD
From FEAR To FAITH
Docetaxel
Class
Antimicrotubule Agents (Taxanes)
MOA
Docetaxel is believed to have a twofold mechanism of antineoplastic activity:
(1) inhibition of microtubular de-polymerization.
(2) attenuation of the effects of bcl-2 and bcl-xL gene expression.
Indications
- Breast cancer
- Non-small cell lung cancer
- Prostate cancer
- Gastric adenocarcinoma
- Head and neck cancer
Pack Size
1’s
Storage
Below 25° C
Available Strength
20mg /6ml Injection
80mg /6ml Injection
120mg /6ml Injection